Covid-19 Vaccine: The countdown to the use of the Corona vaccine has started in the country. The Expert Committee of the Central Drug Standards Control Organization (CDSCO) will review the applications of Pfizer, Serum Institute of India and Bharat Biotak on Wednesday, December 9. These three companies have sought approval for emergency use of Corona vaccine developed by themselves in India. Now everyone’s eyes are on the committee’s review. If the committee does yes then soon the Corona vaccine will start being used in India. First Pfizer, then Serum and on Monday, Bharat Biotech has submitted its applications to the Drug Controller General of India (DCGI).
DCGI has started the work of furthering these match applications. Now the lesson is on the expert committee which will review all three applications. Let us know that all three companies have claimed this, their vaccine has proved to be effective in the trial. However, for storage of the vaccine made by Pfizer, the temperature is minus 70 degrees. In such a situation, maintenance will also be a challenge. However, the serum claims that its vaccine can be taken anywhere from 2 to 8 degrees.
Will usage start this month
For India, which is facing the Corona epidemic, there is hope that emergency use of vaccine may start this month. On the occasion of the foundation stone of the Agra Metro, Prime Minister Narendra Modi said that the country will not have to wait much longer for the vaccine. However, even after this, he has asked to adopt necessary measures like masks and 2 yards. Different companies have also presented complete data of trial in their application. Expert Group will soon examine the data presented by companies. For this reason, it is believed that it may take a time or more to seal the application.
Why emergency use is approved
Emergency use or emergency clearance is also taken for vaccines, medicines, diagnostic tests or medical devices. The Central Drugs Standard Control Organization is a regulator for emergency clearance in India. Vaccine and drug use are generally approved after tests that take several years. But in case of an epidemic, when the benefits appear to be heavy at risk, emergency approval is given.
Government vaccination program
Recently, the government had said on the vaccination program that by July, the preparation of vaccination of about 30 crore people. It was also said by the government that this vaccine will be given to the high risk people first. These include especially the elderly or people seriously suffering from some disease. Apart from this, Corona Warriors are also in its priority. Initially, about 10 million health workers will get corona vaccine dose.
Preparation to buy 150 million doses
Apart from the domestic vaccine, the government is also planning to import a large amount of vaccine. According to media reports, India has made advance booking to buy more than 150 crore doses. According to a report by the Wall Street Journal, India ranks third among the countries with the highest number of vaccine purchase deals. America is at number one and European Union at number two.
Source: www.financialexpress.com
